Enzybel Overview

  • Founded
  • 2006
  • Status
  • Private
  • Employees
  • 7
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 2

Enzybel General Information


Developer of plant and animal-derived enzymes intended to produce and commercialize compounds derived from nature. The company's enzymes are extracts such as papain, bromelain, ficin, and actinidin which are derived from vegetables, plant proteases for food, domestic animals, nutraceuticals, and cosmetics, enabling pharmaceutical companies to improve their products organically.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Specialty Chemicals
Other Industries
Multi-line Chemicals
Primary Office
  • 161/4 bat p, Drève Richelle
  • Drève Richelle
  • 1410 Waterloo
  • Belgium
+32 02 000 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Enzybel Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 09-Feb-2011 Completed Generating Revenue
1. Early Stage VC Completed Startup
To view Enzybel’s complete valuation and funding history, request access »

Enzybel Patents

Enzybel Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
ES-369578-A1 Method for separating extract of hops into soft resins and hard resins Expired 17-Jul-1968 00000000
GB-1241896-A Method for separating extract of hops into soft resins and hard resins Expired 17-Jul-1968 00000000
DE-1933703-A1 Process for the separation of a hop extract into soft and hard resins Pending 17-Jul-1968 00000000
GB-1151465-A Process for preparing hop-extract and products obtained thereby Expired 14-Nov-1966 C12C3/08

Enzybel Executive Team (6)

Name Title Board Seat Contact Info
Patrick Deprez Chief Technical Officer
Adas Widiasmoro General Manager
Nicolas Chatelain Business Developer
Erwin Kooij Manager, Sales
You’re viewing 4 of 6 executive team members. Get the full list »

Enzybel Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Enzybel Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Science Center Accelerator/Incubator Minority 000 0000 000000 0
Florinvest Corporate Venture Capital Minority 000 0000 000000 0
To view Enzybel’s complete investors history, request access »